Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Hybrid Closed-Loop Control Is Safe and Effective for People with Type 1 Diabetes Who Are at Moderate to High Risk for Hypoglycemia.

Anderson SM, Buckingham BA, Breton MD, Robic JL, Barnett CL, Wakeman CA, Oliveri MC, Brown SA, Ly TT, Clinton PK, Hsu LJ, Kingman RS, Norlander LM, Loebner SE, Reuschel-DiVirglio S, Kovatchev BP.

Diabetes Technol Ther. 2019 Jun;21(6):356-363. doi: 10.1089/dia.2019.0018. Epub 2019 May 16.

PMID:
31095423
2.

Predictive hyperglycemia and hypoglycemia minimization: In-home double-blind randomized controlled evaluation in children and young adolescents.

Forlenza GP, Raghinaru D, Cameron F, Wayne Bequette B, Peter Chase H, Paul Wadwa R, Maahs DM, Jost E, Ly TT, Wilson DM, Norlander L, Ekhlaspour L, Min H, Clinton P, Njeru N, Lum JW, Kollman C, Beck RW, Buckingham BA; In-Home Closed-Loop (IHCL) Study Group.

Pediatr Diabetes. 2018 May;19(3):420-428. doi: 10.1111/pedi.12603. Epub 2017 Nov 20.

3.

Home use of a bihormonal bionic pancreas versus insulin pump therapy in adults with type 1 diabetes: a multicentre randomised crossover trial.

El-Khatib FH, Balliro C, Hillard MA, Magyar KL, Ekhlaspour L, Sinha M, Mondesir D, Esmaeili A, Hartigan C, Thompson MJ, Malkani S, Lock JP, Harlan DM, Clinton P, Frank E, Wilson DM, DeSalvo D, Norlander L, Ly T, Buckingham BA, Diner J, Dezube M, Young LA, Goley A, Kirkman MS, Buse JB, Zheng H, Selagamsetty RR, Damiano ER, Russell SJ.

Lancet. 2017 Jan 28;389(10067):369-380. doi: 10.1016/S0140-6736(16)32567-3. Epub 2016 Dec 20. Erratum in: Lancet. 2017 Jan 28;389(10067):368. Lancet. 2017 Feb 4;389(10068):e2.

4.

Training of public health personnel in handling CBRN emergencies: a table-top exercise card concept.

Sandström BE, Eriksson H, Norlander L, Thorstensson M, Cassel G.

Environ Int. 2014 Nov;72:164-9. doi: 10.1016/j.envint.2014.03.009. Epub 2014 Apr 16.

PMID:
24742601
5.

The Cuban paradox.

Birch SE, Norlander L.

Am J Nurs. 2007 Mar;107(3):75-7, 79. No abstract available.

PMID:
17314570
6.

Formation and operation of a statewide commission on end-of-life care in Minnesota.

Norlander L, Ratner E.

J Palliat Med. 2004 Dec;7(6):839-45.

PMID:
15684851
7.

The kitchen table discussion: a creative way to discuss end-of-life issues.

Norlander L, McSteen K.

Home Healthc Nurse. 2000 Sep;18(8):532-9; quiz 539-40.

PMID:
11951306
8.

The relationship of pain and suffering in a hospice population.

Baines BK, Norlander L.

Am J Hosp Palliat Care. 2000 Sep-Oct;17(5):319-26.

PMID:
11886056
9.

The ballet of baseball: lessons of the game for hospice.

Norlander L, Grimmer T.

Am J Hosp Palliat Care. 2000 Nov-Dec;17(6):415-8.

PMID:
11886044
10.

Death at home following a targeted advance-care planning process at home: the kitchen table discussion.

Ratner E, Norlander L, McSteen K.

J Am Geriatr Soc. 2001 Jun;49(6):778-81.

PMID:
11454117
11.

A case of Q fever acquired in Sweden and isolation of the probable ethiological agent, Coxiella burnetii from an indigenous source.

Rustscheff S, Norlander L, Macellaro A, Sjöstedt A, Vene S, Carlsson M.

Scand J Infect Dis. 2000;32(6):605-7.

PMID:
11200368
12.

The Minnesota Partnership to improve end-of-life care.

Ratner E, Norlander L.

Minn Med. 2000 May;83(5):43-4. No abstract available.

PMID:
10832314
13.

Q fever epidemiology and pathogenesis.

Norlander L.

Microbes Infect. 2000 Apr;2(4):417-24. Review.

PMID:
10817644
14.

Early cytokine induction in mouse P388D1 macrophages infected by Coxiella burnetii.

Tujulin E, Lilliehöök B, Macellaro A, Sjöstedt A, Norlander L.

Vet Immunol Immunopathol. 1999 May;68(2-4):159-68.

PMID:
10438316
15.

Effect of endocytosis inhibitors on Coxiella burnetii interaction with host cells.

Tujulin E, Macellaro A, Lilliehöök B, Norlander L.

Acta Virol. 1998 Jun;42(3):125-31.

PMID:
9842441
16.

Identification of a 71-kilodalton surface-associated Hsp70 homologue in Coxiella burnetii.

Macellaro A, Tujulin E, Hjalmarsson K, Norlander L.

Infect Immun. 1998 Dec;66(12):5882-8.

17.

Genotypic and phenotypic characterization of two Swedish isolates and two prototypic strains of Coxiella burnetii.

Sjöstedt A, Göransson I, Macellaro A, Norlander L.

FEMS Immunol Med Microbiol. 1998 Feb;20(2):165-72.

18.

Specific detection of Coxiella burnetii through partial amplification of 23S rDNA.

Ibrahim A, Norlander L, Macellaro A, Sjöstedt A.

Eur J Epidemiol. 1997 Apr;13(3):329-34.

PMID:
9258533
19.

A survey of Q-fever in Sweden.

Macellaro A, Akesson A, Norlander L.

Eur J Epidemiol. 1993 Mar;9(2):213-6.

PMID:
8519360
20.

Analysis of the V antigen lcrGVH-yopBD operon of Yersinia pseudotuberculosis: evidence for a regulatory role of LcrH and LcrV.

Bergman T, Håkansson S, Forsberg A, Norlander L, Macellaro A, Bäckman A, Bölin I, Wolf-Watz H.

J Bacteriol. 1991 Mar;173(5):1607-16.

21.

[Q fever occurs even in Sweden].

Akesson A, Norlander L.

Lakartidningen. 1991 Jan 16;88(3):149. Swedish. No abstract available.

PMID:
1999977
22.

Isolation of Coxiella burnetii in Sweden.

Akesson A, Krauss H, Thiele HD, Macellaro A, Schwan O, Norlander L.

Scand J Infect Dis. 1991;23(2):273-4.

PMID:
1853178
23.

Epidemiology of Q fever in Sweden.

Akesson A, Macellaro A, Tüll P, Williams JC, Norlander L.

Scand J Infect Dis. 1991;23(2):153-7.

PMID:
1853162
24.

Diagnosing the cat.

Norlander L.

Am J Nurs. 1988 Feb;88(2):266. No abstract available.

PMID:
3341398
25.

Identification and mapping of the temperature-inducible, plasmid-encoded proteins of Yersinia spp.

Bölin I, Forsberg A, Norlander L, Skurnik M, Wolf-Watz H.

Infect Immun. 1988 Feb;56(2):343-8.

26.

Molecular cloning and expression of calcium-regulated, plasmid-coded proteins of Y. pseudotuberculosis.

Forsberg A, Bölin I, Norlander L, Wolf-Watz H.

Microb Pathog. 1987 Feb;2(2):123-37.

PMID:
3507554
28.

Studies by electron-paramagnetic-resonance spectroscopy of the molybdenum centre of aldehyde oxidase.

Bray RC, George GN, Gutteridge S, Norlander L, Stell JG, Stubley C.

Biochem J. 1982 Apr 1;203(1):263-7.

29.

Deoxyribonucleic acid modifications and restriction endonuclease production in Neisseria gonorrhoeae.

Norlander L, Davies JK, Hagblom P, Normark S.

J Bacteriol. 1981 Feb;145(2):788-95.

30.

Cefuroxime treatment of urethritis caused by a beta-lactamase-producing strain of Neisseria gonorrhoeae.

Normark S, Elmros T, Norlander L, Kjellberg E, Holm S, Burman LA, Bergström S.

Acta Derm Venereol. 1980;60(3):277-9.

PMID:
6158239
31.

Genetic and physiological basis for diversity in the structure of the cell surface of Neisseria gonorrhoeae.

Norlander L, Norqvist A, Davies J, Magnusson KE, Normark S.

Scand J Infect Dis Suppl. 1980;Suppl 24:158-61. No abstract available.

PMID:
6111122
32.

Effect of colony type and pH on surface charge and hydrophobicity of Neisseria gonorrhoeae.

Magnusson KE, Kihlström E, Norlander L, Norqvist A, Davies J, Normark S.

Infect Immun. 1979 Nov;26(2):397-401.

33.

Genetic basis for colonial variation in Neisseria gonorrhoeae.

Norlander L, Davies J, Norqvist A, Normark S.

J Bacteriol. 1979 Jun;138(3):762-9.

34.

Genetic exchange mechanisms in Neisseria gonorrhoeae.

Norlander L, Davies J, Normark S.

J Bacteriol. 1979 Jun;138(3):756-61.

35.

[Development of antibiotic resistance in gram-negative bacteria].

Bergström S, Elmros T, Holm S, Norlander L, Normark S.

Lakartidningen. 1978 Sep 27;75(39):3418-20. Swedish. No abstract available.

PMID:
703423
36.

Contribution of a TEM-1-like beta-lactamase to penicillin resistance in Neisseria gonorrhoeae.

Bergström S, Norlander L, Norqvist A, Normark S.

Antimicrob Agents Chemother. 1978 Apr;13(4):618-23.

37.

Septum formation-defective mutant of Escherichia coli.

Normark S, Norlander L, Grundström T, Bloom GD, Boquet P, Frelat G.

J Bacteriol. 1976 Oct;128(1):401-12.

Supplemental Content

Loading ...
Support Center